GB0513778D0 - Combination therapy - Google Patents
Combination therapyInfo
- Publication number
- GB0513778D0 GB0513778D0 GB0513778A GB0513778A GB0513778D0 GB 0513778 D0 GB0513778 D0 GB 0513778D0 GB 0513778 A GB0513778 A GB 0513778A GB 0513778 A GB0513778 A GB 0513778A GB 0513778 D0 GB0513778 D0 GB 0513778D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- combination therapy
- therapy
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0513778A GB0513778D0 (en) | 2005-07-06 | 2005-07-06 | Combination therapy |
MX2007016497A MX2007016497A (en) | 2005-07-06 | 2006-07-03 | Combination therapy. |
PCT/GB2006/002462 WO2007003933A2 (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with azd2171 and gemcitabine |
CA002614002A CA2614002A1 (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with azd2171 and gemcitabine |
EP06755701A EP1901754A2 (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with azd2171 and gemcitabine |
NZ564189A NZ564189A (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with AZD2171 and gemcitabine |
BRPI0612397-0A BRPI0612397A2 (en) | 2005-07-06 | 2006-07-03 | use of azd2171 or a pharmaceutically acceptable salt thereof and gemcitabine, pharmaceutical composition, kit, and method for producing an anti-angiogenic and / or vascular permeability reducing effect in a warm-blooded animal |
KR1020087002092A KR20080031029A (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with azd2171 and gemcitabine |
JP2008519988A JP2009500384A (en) | 2005-07-06 | 2006-07-03 | Combination therapy |
AU2006264620A AU2006264620B2 (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with AZD2171 and gemcitabine |
US11/994,824 US20090176731A1 (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with azd2171 and gemcitabine |
CN2006800245799A CN101217966B (en) | 2005-07-06 | 2006-07-03 | Combination therapy of cancer with AZD2171 and gemcitabine |
ZA200710913A ZA200710913B (en) | 2005-07-06 | 2007-12-14 | Combination therapy of cancer with AZD2171 and gemcitabine |
NO20076657A NO20076657L (en) | 2005-07-06 | 2007-12-28 | Combination therapy of cancer with AZD2171 and gemcitabine |
IL188513A IL188513A0 (en) | 2005-07-06 | 2007-12-31 | Combination therapy of cancer with azd2171 and gemcitabine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0513778A GB0513778D0 (en) | 2005-07-06 | 2005-07-06 | Combination therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0513778D0 true GB0513778D0 (en) | 2005-08-10 |
Family
ID=34856705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0513778A Ceased GB0513778D0 (en) | 2005-07-06 | 2005-07-06 | Combination therapy |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN101217966B (en) |
GB (1) | GB0513778D0 (en) |
ZA (1) | ZA200710913B (en) |
-
2005
- 2005-07-06 GB GB0513778A patent/GB0513778D0/en not_active Ceased
-
2006
- 2006-07-03 CN CN2006800245799A patent/CN101217966B/en not_active Expired - Fee Related
-
2007
- 2007-12-14 ZA ZA200710913A patent/ZA200710913B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200710913B (en) | 2008-12-31 |
CN101217966B (en) | 2011-02-02 |
CN101217966A (en) | 2008-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205935A1 (en) | Non-lithotripsic kidney-stone therapy | |
GB0506147D0 (en) | Therapeutic agents | |
GB0505437D0 (en) | Therapeutic agents | |
GB0505725D0 (en) | Therapeutic agents | |
GB0504206D0 (en) | Combination therapy | |
GB0518819D0 (en) | Therapeutic agents | |
GB0518817D0 (en) | Therapeutic agents | |
GB0509052D0 (en) | Combination therapy | |
GB0417481D0 (en) | Combination therapy | |
GB0516661D0 (en) | Therapeutic agents | |
GB0514738D0 (en) | Therapeutic agents | |
GB0428180D0 (en) | Combination therapy | |
ZA200709627B (en) | Combination therapy | |
GB0507003D0 (en) | Therapeutic | |
GB0424339D0 (en) | Combination therapy | |
GB0518720D0 (en) | Therapeutic combination | |
GB0501655D0 (en) | Therapeutic use | |
GB0421436D0 (en) | Combination therapy | |
GB0421438D0 (en) | Combination therapy | |
GB0502949D0 (en) | Combination therapy | |
GB0500658D0 (en) | Combination therapy | |
GB0500659D0 (en) | Combination therapy | |
GB0513778D0 (en) | Combination therapy | |
GB0506725D0 (en) | Combination therapy | |
GB0506726D0 (en) | Combination therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |